Laidlaw is well known for its skill in managing its clients’ financial needs in a variety of ways. However, a recent lawsuit brought up by our client, Relmada Therapeutics, Inc. may have some people a little concerned about us. This unfortunate lawsuit has been filed against our two principals, Matthew Eitner and James Ahern, and alleges that we breached our fiduciary duty by disclosing confidential information.
These unfortunate allegations have caused us to take a strong look at the way we operate. Is there any truth to the claims made against us by Relmada? Happily, our investigation has revealed no wrongdoing by our principals, but indicates that Relmada is primarily seeking damages from us based on what they believe was damaging information.
We’re not here to throw Relmada under the bus or to point fingers in anyone’s direction. That’s not the way we work at Laidlaw. In fact, when Relmada came to us with concerns in December 2015, we met with them to discuss them in a civil manner. And we came away from the meeting pretty confident of our success and proud of what we had accomplished with them.
Unfortunately, it appears that Relmada did not reach the same conclusion. This is a good indicator of the way that people, and even corporations, simply don’t see eye-to-eye sometimes, even when both are working for the common good. We certainly didn’t do anything that would put Relmada at a disadvantage, and are sure that they are behaving in the same way.
It’s a testament to human decency that things have remained at a reasonable level between our two companies during this process. As we work hard to figure out how to resolve this thing, let it serve as a reminder of the ways that people can work together to accomplish something good. We truly believe that we will find a solution to this situation that pleases everyone.